AI detects a distributed blood metabolomic Systemotype associated with early stage ovarian cancer

Early detection of ovarian cancer remains a clinical challenge because available blood biomarkers lack the sensitivity and specificity required for population screening. We tested whether early-stage ovarian cancer is associated with a distributed physiological state in the circulating metabolome. We analyzed untargeted metabolomic profiles from two independent retrospective cohorts: 91 serum samples (59 ovarian cancer, 32 healthy controls) and 83 plasma samples (63 ovarian cancer, 20 healthy controls).